Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
A patient’s procedures, medications, and characteristics significantly increase the risk of device-related infection.1-7 The TYRX™ Absorbable Antibacterial Envelope significantly reduces the incidence of infection for patients with these risk factors.6,8,10,11
Both the TYRX™ Neuro Absorbable Antibacterial Envelope and the TYRX Cardiac Absorbable Antibacterial Envelope for cardiac implantable electronic devices (CIEDs) are designed to help reduce infection, and they share many of the same features.
As shown, the device type and procedure type influence the risk level to the patient.
Klug D et al. Circulation. 2007;116(12):1349-1355.
Margey R et al. Europace. 2010;12(1):64-70.
Sohail MR et al. Clin Infect Dis. 2007;45(2):166-173.
Lekkerkerker JC et al. Heart. 2009;95(9):715-720.
Romeyer-Bouchard et al. Eur Heart J. 2010;31(2):203-210.
Bloom H et al. Pacing Clin Electrophysiol. 2006;29(2):142-145.
Herce et al. Europace. 2013;15(1):66-70.
Kolek MJ et al. J Cardio Electrophysiol. 2015;26(10):1111-1116.
Shariff N et al. J Cardio Electrophysiol. 2015;26(10):783-789.
Henrikson CA et al. JACC EP.2017;3(10):1158-1167.
Mittal S et al. Heart Rhythm. 2014;11(4):595-601.